What is the clinical significance of an estradiol (Estrogen) level of 20, testosterone level of 9, and Follicle-Stimulating Hormone (FSH) level of 5 in a 46-year-old female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

These hormone levels suggest perimenopause in a 46-year-old female, with the estradiol level of 20 pg/mL being relatively low but still within premenopausal range, the testosterone level of 9 ng/dL being normal for women, and the FSH level of 5 mIU/mL being normal and not yet elevated as would be expected in menopause. The hormonal profile indicates declining ovarian function consistent with the perimenopausal transition.

  • The estradiol level is within the premenopausal range, but on the lower side, which may indicate a decline in ovarian function 1.
  • The testosterone level is within the normal range for women, which is important for maintaining bone density and libido 1.
  • The FSH level is normal and not yet elevated, which suggests that the patient is not yet in menopause 1. No immediate medication is required unless the patient is experiencing bothersome symptoms like hot flashes, night sweats, or mood changes.
  • If symptoms are present, options include low-dose hormonal therapy (such as estradiol 0.5 mg daily with cyclic progesterone 200 mg for 12 days monthly if the uterus is intact), or non-hormonal alternatives like venlafaxine 37.5-75 mg daily or gabapentin 300 mg at bedtime for vasomotor symptoms 1. Regular monitoring of hormone levels every 6-12 months is recommended as the patient approaches menopause.
  • These hormonal changes occur because aging ovaries become less responsive to FSH stimulation, leading to fluctuating estrogen levels before eventually declining to postmenopausal levels, at which point FSH would rise significantly 1.

From the Research

Hormone Levels in a 46-year-old Female

The provided hormone levels are:

  • Estradiol (Estrogen): 20
  • Testosterone: 9
  • Follicle-Stimulating Hormone (FSH): 5

Clinical Significance

The clinical significance of these hormone levels can be understood by considering the normal ranges and the physiological roles of these hormones.

  • Estradiol levels can vary widely throughout a woman's menstrual cycle and menopausal status. However, there is limited information in the provided studies to directly compare the given estradiol level of 20 to a normal range for a 46-year-old female 2.
  • Testosterone levels in women are generally lower than in men, but again, the studies do not provide a direct comparison for the given testosterone level of 9 2.
  • An FSH level of 5 can be considered low to normal, as FSH levels typically increase with age, especially during perimenopause and menopause. The average age of menopause is 51, so a 46-year-old woman may still be in the perimenopausal phase, where hormone levels can fluctuate 3, 4.

Menopausal Status and Hormone Therapy

Considering the menopausal status of a 46-year-old female, it's essential to understand that hormone levels can fluctuate significantly during perimenopause. The decision to initiate hormone therapy (HT) should be based on individual symptoms and medical history, rather than solely on hormone levels 4, 5.

Key Points to Consider

  • The benefits and risks of hormone therapy should be carefully evaluated, taking into account the individual's age, time since menopause, and comorbidity status 4.
  • Different types and routes of administration of estrogen and progesterone can have varying effects on the body, and the choice of therapy should be tailored to the individual's needs 6, 5.
  • Robust reference intervals for estradiol, progesterone, luteinizing hormone, and follicle-stimulating hormone are lacking, making it challenging to determine "normal" levels for a 46-year-old female 2.

Further Evaluation

Given the limited information available, it is essential to consult with a healthcare professional to determine the clinical significance of these hormone levels and to discuss potential treatment options, if necessary. A comprehensive evaluation of the individual's medical history, symptoms, and laboratory results is necessary to provide personalized guidance 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hormone replacement therapy - Current recommendations.

Best practice & research. Clinical obstetrics & gynaecology, 2022

Research

Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestins.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2022

Research

[Basic principles of hormone replacement therapy in the postmenopause].

Therapeutische Umschau. Revue therapeutique, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.